AG99 Glaxosmsc 5.25%

RNS Number:3620P
GlaxoSmithKline Capital PLC
04 March 2008


Publication of Prospectus

The following Securities Note has been approved by the UK Listing Authority and
is available for viewing: Securities Note dated 4 March 2008 relating to the
issue by GlaxoSmithKline Capital plc of �700,000,000 6.375 per cent. Fixed Rate
Notes due 9 March 2039 issued under the �10,000,000,000 EMTN programme and
guaranteed by GlaxoSmithKline plc. 
To view the full document, please paste the following URL into the address bar 
of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/3620p_-2008-3-4.pdf


For further information, please contact:

GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS

Enquiries:

UK Media enquiries:                      Philip Thomson     (020) 8047 5502

European Analyst/Investor enquiries:     David Mawdsley     (020) 8047 5564
                                         Sally Ferguson     (020) 8047 5543

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Securities Note, when read
together with the Issuer's Registration Document, (the "Prospectus") may be
addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries and/or to whom
the offer contained in the Prospectus is not addressed. Prior to relying on the
information contained in the Prospectus you must ascertain from the Prospectus
whether or not you are part of the intended addressees of the information
contained therein. 

Your right to access this service is conditional upon complying with the above 
requirement.  







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

PDIILFLRVSISIIT

Glaxosmsc 5.25% (LSE:AG99)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

Glaxosmsc 5.25% (LSE:AG99)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024